NPI Details
DR. Kent D Schnell, MD is an internal medicine in Pasadena, TX with 31 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Kent D Schnell, MD NPI is 1083797799. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Graduation Year:1995
The provider's business location address is:
5030 CRENSHAW RD
SUITE 120
PASADENA, TX
ZIP 77505-140
Phone: (713) 941-3798
Fax: (713) 943-7481
The NPI 1083797799 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
- Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- Hospital discharge day management, 30 minutes or less (HCPCS:99238)
- 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc (HCPCS:U0002)
- Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
- Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- X-ray of chest, 2 views (HCPCS:71046)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
- Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
The enumeration date for this NPI number is 10/24/2006 and was last updated on 7/24/2015.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | K8477 | TEXAS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 84412K | MEDICARE ID-TYPE UNSPECIFIED | TEXAS | |
| 2 | 043003501 | MEDICAID | TEXAS | |
| 3 | G69880 | MEDICARE UPIN | | |
